Quest Diagnostics vs Idexx Laboratories

Side-by-side comparison of AI visibility scores, market position, and capabilities

Idexx Laboratories leads in AI visibility (94 vs 75)
Quest Diagnostics logo

Quest Diagnostics

LeaderHealthcare Tech

Enterprise

Nation's largest clinical lab with 230M tests/year; $9.8B FY2024 revenue; liquid biopsy and genomic oncology testing growth; consumer-direct app strategy; competes with Labcorp.

AI VisibilityBeta
Overall Score
B75
Category Rank
#24 of 290
AI Consensus
69%
Trend
stable
Per Platform
ChatGPT
68
Perplexity
74
Gemini
80

About

Quest Diagnostics is the nation's leading provider of diagnostic information services, founded in 1967 as MetPath and headquartered in Secaucus, New Jersey, trading on NYSE (DGX). The company processes approximately 230 million clinical laboratory tests annually, serving patients through approximately 2,250 patient service centers, physician offices, hospitals, and health plans across the United States. For FY2024, Quest generated approximately $9.8 billion in total revenues under CEO James Davis, who succeeded Steve Rusckowski in 2022 and has accelerated the company's strategy of expanding consumer access, digital connectivity with ordering physicians, and advanced specialty testing capabilities in oncology, genetics, and infectious disease.

Full profile
Idexx Laboratories logo

Idexx Laboratories

LeaderHealthcare Tech

Enterprise

Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.

AI VisibilityBeta
Overall Score
A94
Category Rank
#19 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
92
Gemini
88

About

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.

Full profile

AI Visibility Head-to-Head

75
Overall Score
94
#24
Category Rank
#19
69
AI Consensus
71
stable
Trend
stable
68
ChatGPT
99
74
Perplexity
92
80
Gemini
88
73
Claude
94
80
Grok
99

Key Details

Category
Enterprise
Enterprise
Tier
Leader
Leader
Entity Type
company
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.